<DOC>
	<DOCNO>NCT01059851</DOCNO>
	<brief_summary>This study investigate whether plasma concentration-time profile pharmacokinetics ( PK ) suvorexant ( MK-4305 ) participant impaired renal function similar observe healthy participant ; evaluate safety tolerability suvorexant participant impair renal function healthy participant .</brief_summary>
	<brief_title>Pharmacokinetics Suvorexant Participants With Impaired Renal Function ( MK-4305-023 ) ( COMPLETED )</brief_title>
	<detailed_description>Study Design : This study plan enroll 16 participant Part I ( 8 participant severe renal impairment control group 8 healthy participant ) 32 participant Part II ( 8 participant moderate renal impairment control group 8 healthy participant ; 8 participant mild renal impairment control group 8 healthy participant ) . Part II conduct primary hypothesis meet Part I significant difference PK suvorexant healthy participant severe renal impairment participant .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Impaired Renal Function Participants : Females reproductive potential must negative pregnancy test agree use ( and/or partner use ) two acceptable method birth control Body Mass Index ( BMI ) ≤40 kg/m^2 Diagnosis renal insufficiency Healthy Participants : Females reproductive potential must negative pregnancy test agree use ( and/or partner use ) two acceptable method birth control Body Mass Index ( BMI ) ≤40 kg/m^2 match BMI ± 5 unit his/her correspond renal participant In general good health Matched age ± 10 year his/her correspond renal participant Impaired Renal Function Participants : Is mentally legally incapacitated History clinically significant psychiatric disorder last year Has rapidly fluctuate renal function demonstrate suspected renal artery stenosis Has kidney transplant Unstable endocrine , gastrointestinal , cardiovascular , hematological , immunological , respiratory , genitourinary disease History cancer ( Some exception apply ) Regular user barbiturate sleep aide Consumes excessive amount alcohol ( &gt; 2 drinks/day ) Consumes excessive amount caffeinated beverage ( &gt; 6/day ) Has major surgery within 4 week Has history significant multiple and/or severe allergy Has history cataplexy Participant work night shift able avoid night shift work study Current history illicit drug abuse Nursing mother Healthy Participants : Is mentally legally incapacitate ; Has history stroke , chronic seizure , major neurological disorder Unstable endocrine , gastrointestinal , cardiovascular , hematological , immunological , respiratory , genitourinary disease History cancer ( Some exception apply ) Regular user barbiturate sleep aide Consumes excessive amount alcohol ( &gt; 2 drinks/day ) Consumes excessive amount caffeinated beverage ( &gt; 6/day ) Has major surgery within 4 week Has history significant multiple and/or severe allergy Has history cataplexy Participant work night shift able avoid night shift work study Current history illicit drug abuse Nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>